Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,841
Sort by:
2018 Europe Coagulation Testing Analyzers and Reagents Market: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 19,700.00
... instrument and consumable suppliers during the next five years. Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, ... established and emerging procedures. Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other ...
March 2018
500 pages
US Breast Cancer Lumpectomy Market, Treatment Cost & Opportunity Analysis 2024
US$ 2,400.00
... License depending on the location. “US Breast Cancer Lumpectomy Market, Treatment Cost & Opportunity Analysis 2024” Report Highlights: Lumpectomy Procedure & Cost Involved Lumpectomy & Mastectomy Reimbursement Analysis Lumpectomy Market Analysis by Technology Presence of Venture ...
March 2018
100 pages
2018 Europe Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Market 2021: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 19,700.00
... Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. Review ... test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...
February 2018
630 pages
Blood Culture Tests-Asia Pacific Market Status and Trend Report 2013-2023
US$ 3,480.00
... of Blood Culture Tests by types and applications Cost and profit status of Blood Culture Tests, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Blood Culture Tests market as: Asia Pacific Blood Culture Tests Market: Regional ...
February 2018
158 pages
